Leadership Update Recent appointment of a new CEO and board member, Richard Roberts, signals leadership change and potential strategic pivots. This opening creates an opportunity to engage for partnerships, funding rounds, and pilot collaborations aligned with a fresh growth agenda.

Growth Narrative Active participation in industry events and recognition as a Rising Star with UCSF Health Hub and Edison Accelerator suggests momentum and credibility. Leverage this to approach hospitals and health networks with co-marketing, pilot programs, and referral partnerships.

Product Fit AI-powered non-invasive cCT analysis software producing a 3D heart model positions CardioWise for collaboration with radiology departments and cardiology groups seeking advanced visualization, workflow integration, and FDA-cleared tools in clinical pathways.

Regulatory Milestones FDA 510(k) clearance for SQuEEZ indicates regulatory validation and potential for expanding use cases. Position target buyers around compliance-driven procurement cycles and safety/efficacy highlights to justify adoption.

Financial Levers Current revenue range and modest funding suggest a lean, scalable business with room for strategic partnerships, pilots, and licensing deals with mid-market hospitals and clinic networks, especially those seeking cost-effective imaging software.